The use of ECT and MST in treating depression.

Journal article

Electroconvulsive therapy (ECT) has been used clinically since 1938. Its most common use is in the treatment of depression: first line treatment where rapid recovery is a priority, but more frequently as an effective treatment for patients who do not respond to pharmacological and psychological approaches. Whilst it is widely hailed as an effective treatment, concerns about its effect on cognition remain. The development of magnetic seizure therapy (MST) over the past decade has attempted to ...

Expand abstract

Authors: Allan, C; Ebmeier, K

• Publication status: Published
• Journal: International review of psychiatry (Abingdon, England)
• Volume: 23
• Issue: 5
• Pages: 400-412
• Publication date: 2011-10-01
• DOI: 10.3109/09540261.2011.614223
• EISSN: 1369-1627
• ISSN: 0954-0261
• Language: English
• Keywords: Treatment Outcome; Humans; Electroconvulsive Therapy; Cognition; Recurrence; Functional Neuroimaging; Synaptic Transmission; Depressive Disorder, Major; Transcranial Magnetic Stimulation; Drug Resistance; Electrodes; Receptor, Serotonin, 5-HT1A; Patient Selection; Cerebral Cortex; Seizures; Electromagnetic Radiation; Clinical Trials as Topic